ADAM8 Goat Polyclonal Antibody

CAT#: TA302779

Goat Polyclonal Antibody against ADAM8



Need it in bulk or conjugated?
Get a free quote

CNY 5,371.00


货期*
5周

规格
    • 100 ug

Product images

经常一起买 (2)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Transient overexpression lysate of ADAM metallopeptidase domain 8 (ADAM8), transcript variant 2
    • 100 ug

CNY 4,840.00

Specifications

Product Data
Applications PEP-ELISA, WB
Recommend Dilution WB: 1-3µg/ml.
Reactivity Human
Host Goat
Clonality Polyclonal
Immunogen Peptide with sequence C-QRKQGAGAPTAP, from the C Terminus of the protein sequence according to NP_001100.
Formulation Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Concentration lot specific
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Gene Name ADAM metallopeptidase domain 8
Background This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene may be involved in cell adhesion during neurodegeneration. [provided by RefSeq]
Synonyms CD156; CD156a; MS2
Reference Data
Protein Families Druggable Genome, Transmembrane
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...